UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,022,456 | -54.5% | 152,378 | +36.6% | 0.00% | -94.1% |
| Q1 2023 | $2,246,456 | +271.9% | 111,542 | +246.4% | 0.03% | +183.3% |
| Q3 2022 | $604,000 | +46.2% | 32,196 | +45.5% | 0.01% | +9.1% |
| Q2 2022 | $413,000 | +16.7% | 22,130 | +12.9% | 0.01% | +22.2% |
| Q1 2022 | $354,000 | +71.8% | 19,599 | +351.5% | 0.01% | -80.0% |
| Q1 2020 | $206,000 | -17.9% | 4,341 | +24.0% | 0.04% | +164.7% |
| Q4 2019 | $251,000 | -7.4% | 3,500 | -49.3% | 0.02% | +6.2% |
| Q3 2019 | $271,000 | -77.0% | 6,900 | -54.3% | 0.02% | -87.6% |
| Q2 2019 | $1,179,000 | +266.1% | 15,101 | +179.4% | 0.13% | +138.9% |
| Q1 2019 | $322,000 | – | 5,405 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |